ORZeL

Swiss trademark · 462692 · Combined mark · Deleted

Register entry

Registration number
462692
Application number
00346/1999
Status
Deleted
Type
Combined mark
As registered
ORZeL ((fig.))
Filed
Jan 18, 1999
Registered
Jul 5, 1999
Published
Jul 30, 1999
Deleted
Aug 24, 2009
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceutical preparations for the treatment of cancer

As filed

Pharmazeutische Präparate für die Behandlung von Krebs.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2009

    Deleted, not renewed

    Published in Swissreg on 24.08.2009

  2. Dec 3, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 234 of 03.12.2007

  3. Apr 10, 2006

    Transferred

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, New York (NY 10154), USA → Taiho Pharmaceutical Co., Ltd., 1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo, 101-8444, Japan
    Representative
    E. Blum & Co., Patentanwälte, Vorderberg 11, 8044 Zürich → E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 70 of 10.04.2006

  4. Jul 30, 1999

    Registered

    Published in the SOGC no. 146 of 30.07.1999

Parties

Holder

TAIHO PHARMACEUTICAL CO., LTD.

Taiho Pharmaceutical Co., Ltd.

1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo, 101-8444, JP

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.